L&C BIO Co., Ltd
290650·KOSDAQ·4 grantsAmendments merged
- Shares granted, cumulative
- 220,000shares
- Next lockup release
- D-187
- 2027-02-22
Against the share price
At the 2026-08-18 close- Shares with a reason to exercise
- 220,000 shares
- 0.82% of shares outstanding
- Sellable right now
- 150,000 shares
- 68% of the shares with a reason to exercise
- Unrealized paper gain (to the employees)
- ₩5.5B
Potential dilution
Shares by strike price
- ₩52,800Latest price
- ₩35,72170K shares
- ₩24,79070K shares
- ₩23,05080K shares
Below the line (strike < Latest price) sits above the strike price: 220K shares, 100% of the shares still inside their exercise window.
Options the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.
Share price vs. strike price
A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.
- Strike ₩23,05080K sharesabove
- Strike ₩24,79070K sharesabove
- Strike ₩35,72170K sharesabove
Recipients by role
- Registered director2 people45%
- Unregistered officer6 people55%
- Other · unknown1 person0%
Sorted from the relation text written in the filings (9 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers.
Shares granted by year
Cumulative grants per recipient
5 named · 1 withheld| Recipient | Shares, cumulative | Average strike | Exercisable | Paper gain |
|---|---|---|---|---|
| 100,00045.5% | ₩23,920 | 50,000 | ₩2.9B | |
| 50,00022.7% | ₩33,187 | 50,000 | ₩980.7M | |
| 40,00018.2% | ₩32,553 | 40,000 | ₩809.9M | |
| 20,0009.1% | ₩24,790 | — | ₩560.2M | |
| 10,0004.5% | ₩23,050 | 10,000 | ₩297.5M | |
| 00.0% | — | — | — |
Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.
Grant history · lockup schedule
Exercisable shares over time
It rises on the day a lockup ends and falls on the day an exercise window closes. Options actually exercised are not subtracted, because only executives have to report them.
20241 grant · 70,000 sharesReleases 2027-02-22
- Granted2024-02-21
- Exercise starts2027-02-22
- Exercise ends2034-02-21
- Shares granted
- 70,000shares
- Strike price
- 24,790KRW
- Grant method
- New share issuance, Treasury shares
- Approved by
- Board of directors
Above the strike price₩28,010 per share₩2B[Amended] Report on grant of stock options
20231 grant · 80,000 shares
- Granted2023-01-09
- Exercise starts2026-01-10
- Exercise ends2033-01-09
- Shares granted
- 80,000shares
- Strike price
- 23,050KRW
- Grant method
- New share issuance, Treasury shares
- Approved by
- Board of directors
Above the strike price₩29,750 per share₩2.4B[Amended] Report on grant of stock options
20211 grant · 0 shares
- Granted2021-06-25
- Exercise starts2024-06-26
- Exercise ends2031-06-25
- Shares granted
- —
- Strike price
- 32,200KRW
- Grant method
- New share issuance, Treasury shares
- Approved by
- Board of directors
Above the strike price₩20,600 per share[Amended] Report on grant of stock options
20201 grant · 70,000 shares
- Granted2020-11-27
- Exercise starts2022-11-28
- Exercise ends2029-11-27
- Shares granted
- 70,000shares
- Strike price
- 35,721KRW
- Grant method
- New share issuance, Treasury shares
- Approved by
- Board of directors
Above the strike price₩17,079 per share₩1.2B[Amended] Report on grant of stock options
Options actually exercised
These come from ownership reports filed by executives and major shareholders that give a stock option exercise as the reason. Employees have no such reporting duty, so this is not the company's total exercised volume. Reports filed for the same date at the same strike price are merged into one row, and they are not matched to the individual grants listed above.
Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.